North America Archives - Page 20 of 39 - Journal for Clinical Studies

Current Edition

news

The 100 Year History of Greens 1919-2019

Global Clinical Research Print and Logistics since the early 1970s 1919 - Greens was founded just after the end of the Great War as a sole trader calle...

23 January 2019 news | North America | Regional News | Sponsored Articles

Continue Reading →

news

PCI Pharma Services Announces a more than $20 Million Expansion of Biotech Technologies Including Advanced Injectable Delivery Forms

Philadelphia, USA – January 07, 2019 Leading global biopharmaceutical services provider PCI Pharma Services (PCI) has announced a momentous investment in support of b...

22 January 2019 news | North America | Regional News

Continue Reading →

news

Aptinyx stung by pain drug’s mid-stage miss

Aptinyx, an Illinois-based biotech, saw its share value dive roughly 70% Wednesday morning after announcing its lead candidate failed a Phase 2 study of patients w...

17 January 2019 news | North America | Regional News

Continue Reading →

news

Pfizer initiates phase 2b/3 clinical trial for PF-06651600, an oral JAK3 inhibitor, for the treatment of patients with moderate to severe alopecia areata

Pfizer Inc. (NYSE: PFE) announced the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate ...

10 January 2019 news | North America | Regional News

Continue Reading →

news

Lynparza meets primary endpoint in Phase III SOLO-3 trial for the treatment of relapsed BRCA-mutated advanced ovarian cancer

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) announced positive results from the randomised, open-label...

10 January 2019 news | North America

Continue Reading →

news

Phase 3 Trial of Rova T as Second-line Therapy for Advanced Small-Cell Lung Cancer Halted

AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab ...

10 January 2019 news | North America | Regional News

Continue Reading →

Europe

Nanobiotix and MD Anderson Cancer Center announce a large-scale, comprehensive clinical collaboration on NBTXR3

Collaboration will initially support nine new phase I/II clinical trials with Nanobiotix’s first-in-class agent NBTXR3 for use in treating six cancer types - head ...

10 January 2019 Europe | news | North America | Regional News

Continue Reading →

news

AbbVie and J&J dominate clinical trial development in psoriatic arthritis, says GlobalData

AbbVie and Johnson & Johnson (J&J) are responsible for 47 of the 121 industry sponsored clinical trials in the psoriatic arthritis space, according to GlobalD...

10 January 2019 news | North America | Regional News

Continue Reading →

news

PCI Pharma Services Announces a more than $20 Million Expansion of Biotech Technologies Including Advanced Injectable Delivery Forms

Philadelphia, USA – January 07, 2019 Leading global biopharmaceutical services provider PCI Pharma Services (PCI) has announced a momentous investment in support of b...

7 January 2019 news | North America | Regional News

Continue Reading →

Europe

WU biomedical engineer makes a significant step toward precision medicine

In 2015, then President Barack Obama launched a precision medicine initiative, saying that its promise was "delivering the right treatments, at the right time, every ...

20 December 2018 Europe | news | North America | Regional News

Continue Reading →